The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 28, 2018

Filed:

Mar. 11, 2014
Applicant:

Angelica Therapeutics, Inc., Emeryville, CA (US);

Inventors:

Claude Geoffrey Davis, Auburn, CA (US);

Deepshikha Datta, San Francisco, CA (US);

Matthew Paul Baker, Suffolk, GB;

Alyson Jane Rust, Suffolk, GB;

Simon Keen, Cambridge, GB;

Assignee:

ANGELICA THERAPEUTICS, INC., Auburn, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 14/34 (2006.01); A61K 39/39 (2006.01); A61K 38/16 (2006.01); A61K 38/20 (2006.01); A61K 39/395 (2006.01); A61K 45/06 (2006.01); C07K 14/55 (2006.01); C07K 16/32 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 14/34 (2013.01); A61K 38/164 (2013.01); A61K 38/2013 (2013.01); A61K 39/39 (2013.01); A61K 39/3955 (2013.01); A61K 39/39558 (2013.01); A61K 45/06 (2013.01); C07K 14/55 (2013.01); C07K 16/32 (2013.01); A61K 2039/585 (2013.01); C07K 2317/24 (2013.01); C07K 2317/622 (2013.01); C07K 2317/73 (2013.01); C07K 2319/55 (2013.01);
Abstract

The present application relates to compositions of modified toxins exhibiting cytotoxicity and/or reduced immunogenicity. Also provided are polypeptide toxophores from a modified diphtheria toxin, where modifications are in at least one amino acid residue of at least one T-cell epitope. Another aspect relates to a fusion protein which comprises a modified diphtheria toxin and a non-diphtheria toxin fragment that is a cell binding portion. Another aspect relates to the use of a modified diphtheria toxin for the treatment of a malignant disease or a non-malignant disease. A modified diphtheria toxin or fusion protein may be administered with one or more other agents.


Find Patent Forward Citations

Loading…